A Phase 1 Study of (131)I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety

INTRODUCTION: (131)I-CLR1404 is a small molecule that combines a tumor-targeting moiety with a therapeutic radioisotope. The primary aim of this phase 1 study was to determine the administered radioactivity expected to deliver 400 mSv to the bone marrow. The secondary aims were to determine the phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Grudzinski, Joseph J., Titz, Benjamin, Kozak, Kevin, Clarke, William, Allen, Ernest, Trembath, LisaAnn, Stabin, Michael, Marshall, John, Cho, Steve Y., Wong, Terence Z., Mortimer, Joanne, Weichert, Jamey P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234270/
https://www.ncbi.nlm.nih.gov/pubmed/25402488
http://dx.doi.org/10.1371/journal.pone.0111652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234270/
https://www.ncbi.nlm.nih.gov/pubmed/25402488
http://dx.doi.org/10.1371/journal.pone.0111652

Ejemplares similares